By G HossainPosted on May 16, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss. Lilly Makes $1.3B RNA Editing Bet With Rznomics to Build Out Hearing Loss Pipeline Post navigation UPDATED: With Novo CEO’s Sudden Exit, Analysts Worry ‘There’s Something Pretty Wrong Here’BioMarin Expands Enzyme Expertise With $270M Inozyme Buy